Event JSON
{
"id": "8a407ea5615b7caf31fc73eb25a9357c588549f038b03dbb23151b0024e8940a",
"pubkey": "b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"created_at": 1735304560,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/biontech-enters-settlement-us-agency-125333042.html"
],
[
"subject",
"BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties"
],
[
"published_at",
"1735304013"
],
[
"image",
"https://media.zenfs.com/en/reuters-finance.com/5eb866174a8e34b9ac245ec776b2cb5f"
],
[
"p",
"b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/reuters-finance.com/5eb866174a8e34b9ac245ec776b2cb5f"
],
[
"t",
"Technology:perspective"
],
[
"summary",
"BioNTech has agreed to pay $791.5 million to the US National Institutes of Health and $467 million to the University of Pennsylvania to settle disputes over royalty payments related to its COVID-19 vaccine. The agreements follow lawsuits filed by the two institutions, which claimed that BioNTech had underpaid royalties. The company has taken licenses for certain patents from the NIH and the University of Pennsylvania, and the agreements will dismiss the lawsuits."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqhrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guq4j834n\nhttps://media.zenfs.com/en/reuters-finance.com/5eb866174a8e34b9ac245ec776b2cb5f\n\nhttps://finance.yahoo.com/news/biontech-enters-settlement-us-agency-125333042.html",
"sig": "9d54ba12f784d967f9a289398e69dea59f0acbff04b876b886a6609e556cd67648583a43e6eb11d2370b59661a69474e8e78f2e6ff7bd67b7ea4421bf25d49d7"
}